CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis
2023 · Nature Cancer · 120 citations
https://doi.org/10.1038/s43018-023-00600-4
E
Emily Lerner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
391
Citations
8
h-index
7
i10-index
Emily Lerner is an academic researcher. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Brain Metastases and Treatment & Cancer Immunotherapy and Biomarkers. The author has an h-index of 8, co-authored 57 publications.
ORCID: 0000-0003-1597-8581Papers by this author
worksAntigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion
2024 · Immunity · 72 citations
https://doi.org/10.1016/j.immuni.2024.11.026
Factors Associated With New-Onset Seizures Following Stereotactic Radiosurgery for Newly Diagnosed Brain Metastases
2022 · Advances in Radiation Oncology · 6 citations
https://doi.org/10.1016/j.adro.2022.101054
Combinatorial Checkpoint Blockade and Laser Interstitial Thermal Therapy: A Single Center Study
2024 · Neurosurgery · 0 citations
https://doi.org/10.1227/neu.0000000000002810_120
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat